Healthcare Resource Use and Costs Associated with Organ Damage in Newly Diagnosed Adults with Systemic Lupus Erythematosus in the UK.

Stirnadel-Farrant, Heide A; Golam, Sarowar M; Naisbett-Groet, Barbara; Gibson, Danny; Langham, Julia; Langham, Sue; Samnaliev, Mihail.

Afiliação

Stirnadel-Farrant HA; BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK. Heide.Stirnadel-Farrant@astrazeneca.com.
Golam SM; Oncology Business Unit, AstraZeneca, AstraZeneca Academy House, 136 Hills Road, Cambridge, CB2 8PA, UK. Heide.Stirnadel-Farrant@astrazeneca.com.
Naisbett-Groet B; BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden.
Gibson D; BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.
Langham J; Health Economics, AstraZeneca, Cambridge, UK.
Langham S; Epidemiology Group, Maverex Limited, Newcastle-Upon-Tyne, UK.
Samnaliev M; Health Economics Group, Maverex Limited, Newcastle-Upon-Tyne, UK.

Rheumatol Ther ; 10(5): 1183-1197, 2023 Oct.

Article em En | MEDLINE | ID: mdl-37400683